HNF1A Mutations and Beta Cell Dysfunction in Diabetes
- PMID: 35328643
- PMCID: PMC8948720
- DOI: 10.3390/ijms23063222
HNF1A Mutations and Beta Cell Dysfunction in Diabetes
Abstract
Understanding the genetic factors of diabetes is essential for addressing the global increase in type 2 diabetes. HNF1A mutations cause a monogenic form of diabetes called maturity-onset diabetes of the young (MODY), and HNF1A single-nucleotide polymorphisms are associated with the development of type 2 diabetes. Numerous studies have been conducted, mainly using genetically modified mice, to explore the molecular basis for the development of diabetes caused by HNF1A mutations, and to reveal the roles of HNF1A in multiple organs, including insulin secretion from pancreatic beta cells, lipid metabolism and protein synthesis in the liver, and urinary glucose reabsorption in the kidneys. Recent studies using human stem cells that mimic MODY have provided new insights into beta cell dysfunction. In this article, we discuss the involvement of HNF1A in beta cell dysfunction by reviewing previous studies using genetically modified mice and recent findings in human stem cell-derived beta cells.
Keywords: GWAS; HNF1A; MODY; MODY3; beta cell dysfunction; dedifferentiation; diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells.Nat Commun. 2021 May 25;12(1):3133. doi: 10.1038/s41467-021-22843-4. Nat Commun. 2021. PMID: 34035238 Free PMC article.
-
Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes.Clin Genet. 2016 Dec;90(6):486-495. doi: 10.1111/cge.12757. Epub 2016 Mar 4. Clin Genet. 2016. PMID: 26853433
-
Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.Dan Med J. 2015 Sep;62(9):B4860. Dan Med J. 2015. PMID: 26324089 Clinical Trial.
-
Novel insights into genetics and clinics of the HNF1A-MODY.Endocr Regul. 2019 Apr 1;53(2):110-134. doi: 10.2478/enr-2019-0013. Endocr Regul. 2019. PMID: 31517624 Review.
-
HNF1A:From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.Front Endocrinol (Lausanne). 2022 Mar 1;13:829565. doi: 10.3389/fendo.2022.829565. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35299962 Free PMC article. Review.
Cited by
-
The Role of Genetic Variation in Modulating the Effects of Blended Fruits and Vegetables Versus Fruit- and Vegetable-Coated Food Products on Antioxidant Capacity, DNA Protection, and Vascular Health: A Randomized Controlled Trial.Nutrients. 2025 Jun 18;17(12):2036. doi: 10.3390/nu17122036. Nutrients. 2025. PMID: 40573148 Free PMC article. Clinical Trial.
-
Monogenic Defects of Beta Cell Function: From Clinical Suspicion to Genetic Diagnosis and Management of Rare Types of Diabetes.Int J Mol Sci. 2024 Sep 29;25(19):10501. doi: 10.3390/ijms251910501. Int J Mol Sci. 2024. PMID: 39408828 Free PMC article. Review.
-
Wolfram syndrome 2 gene (CISD2) deficiency disrupts Ca2+-mediated insulin secretion in β-cells.Mol Metab. 2025 Jun;96:102140. doi: 10.1016/j.molmet.2025.102140. Epub 2025 Apr 4. Mol Metab. 2025. PMID: 40189101 Free PMC article.
-
Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DM.Biomolecules. 2025 Mar 14;15(3):414. doi: 10.3390/biom15030414. Biomolecules. 2025. PMID: 40149950 Free PMC article. Review.
-
Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine.J Diabetes Investig. 2024 Apr;15(4):410-422. doi: 10.1111/jdi.14149. Epub 2024 Jan 23. J Diabetes Investig. 2024. PMID: 38259175 Free PMC article. Review.
References
-
- Pihoker C., Gilliam L.K., Ellard S., Dabelea D., Davis C., Dolan L.M., Greenbaum C.J., Imperatore G., Lawrence J.M., Marcovina S.M., et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: Results from the SEARCH for Diabetes in Youth. J. Clin. Endocrinol. Metab. 2013;98:4055–4062. doi: 10.1210/jc.2013-1279. - DOI - PMC - PubMed
-
- Shepherd M., Shields B., Hammersley S., Hudson M., McDonald T.J., Colclough K., Oram R.A., Knight B., Hyde C., Cox J., et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016;39:1879–1888. doi: 10.2337/dc16-0645. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical